Latest investigations into retatritide peptide demonstrate notable potential for addressing obesity and type 2 diabetes mellitus. The peptide, a dual stimulator of GLP-1 receptor and GIP receptor, seems to provide enhanced weight loss and blood sugar control versus existing therapies. Further res